title: [New indications of ivermectin].
abstract: BACKGROUND
  Ivermectin is a semi-synthetic derivative of a family of macrocyclic lactones. This drug has a broad-spectrum anti-parasitic effect against various nematodes and ectoparasites. CURRENT KNOWLEDGE AND KEY-POINTS: Onchocerciasis and lymphatic filariasis are common indications. More recently ivermectin has been recommended in the treatment of strongyloidiasis and scabies.
  
  
  CONCLUSIONS
  Promising results have been shown in the treatment of ascariasis, cutaneous larva migrans, loiasis and head lice.
authors.affiliation: Département des maladies infectieuses, tropicales et de parasitologie-mycologie, hôpital de la Pitié-Salpêtrière, 47-83, boulevard de l'Hôpital, 75651 Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Caumes
authors.forename: M
authors.initials: M
authors.lastname: Danis
mesh_terms: D000977:Antiparasitic Agents / Q000627:therapeutic use*; D006801:Humans; D007559:Ivermectin / Q000627:therapeutic use*; D010272:Parasitic Diseases / Q000188:drug therapy*
chemical_list: D000977:Antiparasitic Agents; D007559:Ivermectin